In ovarian cancer, hypoxia induces angiogenesis in humans and mice, where CD4+, CD25+ and tumour-infiltrating regulatory T cells secrete high quantities of VEGFA and promote the dissemination of endothelial cells, both ‘in vitro’ and ‘in vivo’. Here, VEGFA is linked to neoplasm.